LORLATINIB

7455 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LORLATINIB:

# Side effect Count
0 DEATH 1486
1 NEOPLASM PROGRESSION 620
2 OFF LABEL USE 457
3 HALLUCINATION 447
4 WEIGHT INCREASED 433
5 BLOOD CHOLESTEROL INCREASED 381
6 DYSPNOEA 293
7 MALIGNANT NEOPLASM PROGRESSION 285
8 OEDEMA 280
9 FATIGUE 273
See all common reactions for LORLATINIB

LORLATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 17 0.6538
1 RETRO-ORBITAL NEOPLASM 17 0.3208
2 NEUROBLASTOMA RECURRENT 18 0.0887
3 MEAN ARTERIAL PRESSURE INCREASED 6 0.0857
4 BRAIN RADIATION NECROSIS 6 0.0811
5 VERY LOW DENSITY LIPOPROTEIN INCREASED 17 0.0766
6 LIPIDS ABNORMAL 47 0.0649
7 BODY SURFACE AREA INCREASED 7 0.0543
8 NON-SMALL CELL LUNG CANCER METASTATIC 37 0.0421
9 LIPIDS INCREASED 83 0.0411
See all enriched reactions for LORLATINIB